EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

A new study published in the journal of The Lancet showed that, with no new safety issues, gepotidacin showed no inferiority ...

An oral dose of zoliflodacin – vying to become the first in the new class of bacterial ... to ceftriaxone and azithromycin, with no cross-resistance with other antibiotics.

GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin that could spell the end of a decades-long drought in new oral therapies for gonorrhoea. In the EAGLE-1 ...

For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone ...

Medicare Part D may typically cover most outpatient prescription medications. These include antibiotics like azithromycin. Learn more here.

UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.

Antibiotic-resistant illnesses, the World Health Organization says they are a global health concern, but the discovery of a ...

(CNN) — A new type of antibiotic for treatment of urinary ... as an injection paired with orally taking the antibiotic azithromycin. The trial data, which is being presented at the European ...

Today, only one oral antibiotic is left: the macrolide, azithromycin. And this medicine might not work for much longer. The 2022 study found mutations that confer resistance to azithromycin are ...